Indivior Pharmaceuticals (INDV) EBT Growth (1y) (2025 - 2026)

Indivior Pharmaceuticals (INDV) EBT Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 48.64%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -1.94%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -393.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -24.84%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 92.01%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1,578.91%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 45.00%
10 Indivior Pharmaceuticals 1.00 Bn 829.65 Mn 277.00 Mn 94.92%

Historic Data

Download Data
DateValue
Mar 31, 2026 94.92%
Dec 31, 2025 113.16%
Sep 30, 2025 23.33%
Jun 30, 2025 151.24%
Mar 31, 2025 -19.18%